Colossal Says Its 3D-Printed Artificial Egg Could Expand Bird Biotechnology

A New Container for Growing Bird Embryos

Colossal Biosciences says it has developed what it calls a “fully artificial egg,” a device intended to let bird embryos continue developing outside a natural eggshell. The claim, reported by MIT Technology Review, is part of the company’s broader effort to build reproductive technologies that could eventually support avian conservation work and its longer-term de-extinction ambitions.

The device is better described, based on the source text, as an artificial eggshell system. Colossal took the contents of recently laid chicken eggs and transferred them into transparent 3D-printed containers, where the embryos continued growing. The shell structure is described as an oval printed lattice coated internally with a silicone-based membrane that allows oxygen to pass through, mimicking one of a real shell’s central functions. A window at the top allows researchers to observe development.

The images and descriptions are striking, but the underlying importance is technical rather than theatrical. If embryos can be reliably sustained in a controllable artificial environment, researchers may gain a more flexible platform for developmental manipulation, observation, and possibly conservation-oriented breeding strategies.

Why Colossal Built It

Colossal was founded in 2021 and has positioned itself around gene editing and reproductive technologies aimed at reviving extinct species, including the woolly mammoth. In the avian context, the company has pointed to species such as the dodo and the giant moa.

According to the source text, the artificial eggshell could help with at-risk bird conservation and might eventually be relevant to efforts to recreate very large extinct birds whose eggs would be difficult to replicate naturally. Colossal even showed a prototype large enough that staff reportedly nicknamed it the “salad spinner,” underscoring how far the company is thinking beyond chicken-scale embryology.

The technical appeal is obvious. A controllable artificial shell could make it easier to monitor embryos, alter conditions, or work with species whose reproductive biology is difficult to access. For a company focused on large-scale genetic intervention in birds, such a platform could become a foundational tool rather than a one-off experiment.

What the Company Actually Demonstrated

The source text describes a process in which recently laid chicken eggs were carefully emptied into the artificial containers, where the embryos continued developing. Colossal’s chief biology officer said seeing the embryos moving inside the artificial eggs was a powerful proof of concept. But the report also makes clear that the technology should not be overstated.

Calling the system a “fully artificial egg” invites a broader interpretation than the source material supports. The embryos still began as conventional eggs laid by chickens. What Colossal appears to have demonstrated is a viable artificial incubation vessel that can substitute for parts of the eggshell environment after transfer, not a system that creates avian life from scratch.

That distinction matters because it separates a meaningful bioengineering achievement from a much larger claim that has not been established in the supplied text.

Potential Uses in Conservation and Research

Even within those limits, the platform could prove useful. Bird conservation often runs into reproductive bottlenecks, especially when dealing with rare species, fragile eggs, or a need for close embryonic monitoring. An artificial shell environment could give researchers a way to inspect development through a viewing window, manage gas exchange, and potentially standardize conditions.

For gene-editing workflows, the benefits may be even clearer. A more accessible embryonic environment could simplify interventions or observation during critical stages of growth. The source text does not claim that Colossal has solved these downstream challenges, but it does suggest why the company views the eggshell system as a step toward larger ambitions.

The moa example illustrates the concept. Recreating an extinct 12-foot-tall bird would require far more than a big incubator. Scientists would need to reconstruct genomic information from ancient remains and introduce large numbers of edits into an existing bird genome, a challenge the source text explicitly says remains technically difficult. Still, if the end goal involves gestating very large avian embryos, then scalable artificial shell systems could become relevant infrastructure.

Where the Skepticism Comes In

The report also notes that some scientists believe Colossal is taking too much credit for its artificial eggshell work, implying that elements of the concept draw on prior scientific foundations. That caution is important. In frontier biotech, companies often present a complex body of incremental progress as a singular breakthrough. The supplied text does not resolve that debate, so the fairest reading is that Colossal has produced a notable demonstration while questions remain about novelty, reproducibility, and the extent of the advance.

There is a broader pattern here. Colossal operates at the intersection of legitimate technical experimentation and high-visibility storytelling. That can attract capital and attention, but it also raises the burden of distinguishing between what has been shown, what is plausible, and what remains speculative.

In this case, the evidence in the source text supports the claim that chicken embryos continued growing inside 3D-printed, membrane-lined containers. It does not support the conclusion that extinct birds are anywhere close to being recreated.

Why the Development Still Matters

The significance of the artificial eggshell is not that it instantly validates de-extinction. It is that reproductive technology often advances through enabling tools that look modest compared with the ambitions built on top of them. If researchers can create more controllable environments for avian embryonic development, they may open new options in conservation biology, developmental research, and gene-editing applications.

The transparent design is especially notable because it allows direct observation. Natural eggs conceal much of embryonic development from view unless they are candled or otherwise imaged indirectly. A system that can sustain development while also improving visibility and access could make experimental iteration faster.

That does not eliminate ethical or technical concerns. Any move toward artificial gestation systems will raise questions about animal welfare, intervention thresholds, and the kinds of species or traits such tools are ultimately used to pursue. The source text does not address those issues in depth, but they are likely to follow as the technology matures.

A Small Step With Outsized Ambitions

Colossal’s artificial eggshell sits in a familiar category of emerging biotech: a genuine platform experiment surrounded by much larger future-facing claims. It appears to be an early proof of concept with plausible applications in bird research and conservation, and perhaps eventual relevance to more ambitious reproductive engineering projects.

The most disciplined interpretation is also the most useful one. Colossal has not shown that extinct birds can be brought back. It has shown that bird embryos can continue developing in a carefully designed, 3D-printed shell substitute. That is a narrower achievement, but not an insignificant one.

If the technology proves reliable and extensible, it could become one of the enabling systems behind future avian biotech work. For now, the artificial egg is less a resurrection machine than a new piece of laboratory infrastructure, one designed for a field that increasingly wants more control over how life develops and where it can be sustained.

This article is based on reporting by MIT Technology Review. Read the original article.